Evidence map›Paper›PMID 35322595›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Kidney Decellularized Extracellular Matrix Enhanced the Vascularization and Maturation of Human Kidney Organoids.

Jin Won Kim, Sun Ah Nam, Jawoon Yi, Jae Yun Kim, Jong Young Lee, Seo-Yeon Park, Tugce Sen, Yoo-Mi Choi, Jae Yeon Lee, Hong Lim Kim and 4 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
34.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Advances in vascularized organoids.Chinese medical journal · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Jin Won KimCell Death Disease Research Center, College of Medicine, The Catholic University of Korea, Seoul, 06591, Korea.
Sun Ah NamCell Death Disease Research Center, College of Medicine, The Catholic University of Korea, Seoul, 06591, Korea.
Jawoon YiSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, 61005, Korea.
Jae Yun KimSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, 790-784, Korea.
Jong Young LeeCell Death Disease Research Center, College of Medicine, The Catholic University of Korea, Seoul, 06591, Korea.
Seo-Yeon ParkCell Death Disease Research Center, College of Medicine, The Catholic University of Korea, Seoul, 06591, Korea.
Tugce SenDepartment of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), Pohang, Kyungbuk, 790-784, Korea.
Yoo-Mi ChoiDepartment of Convergence IT Engineering, Pohang University of Science and Technology, Pohang, 790-784, Korea.
Jae Yeon LeeDepartment of Companion Animal Health, Daegu Haany University, Gyeongsan, 790-784, Republic of Korea.
Hong Lim KimIntegrative Research Support Center, College of Medicine, The Catholic University of Korea, Seoul, 06591, Korea.
Hyung Wook KimDepartment of Internal Medicine, The Catholic University of Korea, St. Vincent's Hospital, Suwon, 16247, Korea.
Jiwhan ParkSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, 61005, Korea.ORCID 0000-0002-5728-912X
Dong-Woo ChoSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, 790-784, Korea.
Yong Kyun KimCell Death Disease Research Center, College of Medicine, The Catholic University of Korea, Seoul, 06591, Korea.ORCID 0000-0002-1871-3549
Pohang University of Science and Technology · KRThe Catholic University of Korea St. Vincent's Hospital · KRCatholic University of Korea · KRDaegu Haany University · KRGwangju Institute of Science and Technology · KR

Funding

Korean Fund for Regenerative MedicineMinistry of Education NRF-2019R1C1C1005403Ministry of Education, Science and Technology NRF-2019R1C1C1005403Ministry of Education, Science and Technology NRF-2020R1A2C200912712Ministry of Education, Science and Technology NRF-2021R1A2B5B01001793Ministry of Health and Welfare 21B0601L1-01Ministry of Science and ICTNational Research Foundation of Korea
6 · The paper itself

Abstract

Kidney organoids derived from human pluripotent stem cells (hPSCs) have extensive potential for disease modelling and regenerative medicine. However, the limited vascularization and immaturity of kidney organoids have been still remained to overcome. Extracellular matrix (ECM) can provide mechanical support and a biochemical microenvironment for cell growth and differentiation. Here in vitro methods using a kidney decellularized extracellular matrix (dECM) hydrogel to culture hPSC-derived kidney organoids, which have extensive vascular network and their own endothelial cells, are reported. Single-cell transcriptomics reveal that the vascularized kidney organoids cultured using the kidney dECM have more mature patterns of glomerular development and higher similarity to human kidney than those cultured without the kidney dECM. Differentiation of α-galactosidase A (GLA)-knock-out hPSCs generated using CRISPR/Cas9 into kidney organoids by the culture method using kidney dECM efficiently recapitulate Fabry nephropathy with vasculopathy. Transplantation of kidney organoids with kidney dECM into kidney of mouse accelerates the recruitment of endothelial cells from the host mouse kidney and maintains vascular integrity with the more organized slit diaphragm-like structures than those without kidney dECM. The kidney dECM methodology for inducing extensive vascularization and maturation of kidney organoids can be applied to studies for kidney development, disease modeling, and regenerative medicine.

Indexed as

OrganoidsPluripotent Stem CellsAnimalsDecellularized Extracellular MatrixEndothelial CellsHumansKidneyMiceDecellularized Extracellular Matrixextracellular matrixkidneyorganoidvascularization

Identifiers

PMID35322595
PMCPMC9130892
OpenAlexW4220675588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.